FDA Grants Tentative Approval To GGI For Pramipexole Dihydrochloride Tablets
Published: 28-Dec-2009
Company also received tentaive approval for Atomoxetine Hydrochloride capsules
The FDA has granted tentative approval to Glenmark Generics US (GGI), a subsidiary of Glenmark Generics, for Pramipexole Dihydrochloride tablets, the generic version of Boehringer Ingelheim’s Mirapex tablets.
The tentative approval for Pramipexole Dihydrochloride tablets is for the 0.125mg, 0.25mg, 0.5mg, 1mg, and 1.5mg strengths.
GGI also received tentative approval for Atomoxetine Hydrochloride capsules, the generic version of Lilly’s Strattera.
Atomoxetine Hydrochloride capsules is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Glenmark’s tentative approval was granted for the 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg strengths.
The company said that based on the tentative approval for Pramipexole Dihydrochloride tablets, it should be able to launch the product in October 2010, or earlier in certain circumstances.
Reportedly, the company has received ten final and five tentative approvals this calendar year and has well over 40 Abbreviated New Drug Applications (ANDA) pending approval with the FDA.
Glenmark’s current marketing portfolio consists of 49 products authoriSed for distribution in the US.
Network Sites

Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
TOPRA
Healthcare Regulatory Affairs ...
Thomson Reuters
The World's Leading Source of Life Sciences Intelligent Information ...
Tarius
Your One Source for Global Regulatory Information ...
Swiss BioAnalytics
Quantitative and Qualitative LC/MS Services for Preclinical and Clinical Trials ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully